NAAA
HAE icon

New Age Alpha Advisors’s Haemonetics HAE Stock Holding History

New Age Alpha Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,829
Closed -$159K – 957
2026
Q1 		$159K Sell
2,829
-71
-2% -$4.62K 0.01% 651
2025
Q4 		$232K Sell
2,900
-9
-0.3% -$605 0.01% 583
2025
Q3 		$142K Sell
2,909
-60
-2% -$3.71K 0.01% 684
2025
Q2 		$222K Buy
+2,969
New +$197K 0.01% 608

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

New Age Alpha Advisors's HAE Position: Q2 2026 in Review

New Age Alpha Advisors sold out of Haemonetics (HAE) in Q2 2026, closing a stake of 2,829 shares — an estimated $159K sold.

New Age Alpha Advisors first reported a position in HAE in Q2 2025 and held it in 4 quarters. The position peaked at $232K in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • New Age Alpha Advisors reported no remaining Haemonetics position as of Q2 2026 after selling out during the quarter.
  • New Age Alpha Advisors sold 2,829 Haemonetics shares in Q2 2026, an estimated $159K.
  • New Age Alpha Advisors first reported a position in Haemonetics in Q2 2025 and held it in 4 quarters.
  • New Age Alpha Advisors's Haemonetics position peaked at $232K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.